Ethyl orthoformate → 2-(1H-tetrazol-1-yl)-6,7-dihydro-5H-cyclopenta[d]pyrimidine-5-carboxylic acid
反応式
FC(F)(F)C(O[Si](C)(C)C)=O.[NH2:12][C:13]1[N:14]=[CH:15][C:16]2[CH:21]([C:22]([OH:24])=[O:23])[CH2:20][CH2:19][C:17]=2[N:18]=1.[CH:25](OCC)(OCC)OCC.[N:35]([Si](C)(C)C)=[N+:36]=[N-:37]>C(OCC)(=O)C>[N:12]1([C:13]2[N:14]=[CH:15][C:16]3[CH:21]([C:22]([OH:24])=[O:23])[CH2:20][CH2:19][C:17]=3[N:18]=2)[CH:25]=[N:35][N:36]=[N:37]1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
Trimethylsilyl trifluoroacetate (1.5 mL, 8.7 mmol) was added to a suspension of 2-amino-6,7-dihydro-5H-cyclopenta[d]pyrimidine-5-carboxylic acid (845 mg, 4.72 mmol) in ethyl acetate (10 mL). A solution was obtained but a precipitate formed within 5 minutes. The reaction mixture was stirred at RT for 5 minutes and triethyl orthoformate (1.4 mL, 8.4 mmol) was added. The mixture was stirred at RT for 5 minutes and azidotrimethylsilane (1.1 mL, 8.4 mmol) was added. The resulting suspension was stirred at RT overnight. The solvent was evaporated. The residue was purified by chromatography on silica gel (80 g cartridge) using CH2Cl2 (A) and CH2Cl2:MeOH:AcOH 90:10:1 (B) with gradient elution (100% A to 100% B over 16 column volumes) to afford crude product which was further purified by preparative HPLC to afford the title compound: NMR 500 MHz (CD3OD) 10.00 (s, 1H); 8.88 (s, 1H); 4.32 (t, 1H); 3.11-3.15 (m, 2H); 2.47-2.63 (m, 2H); LC/MS (M+Na)+ at 255, (M+1)+ at 233, (M+1-N2)+ at 205.
後処理
- customA solution was obtained
- customa precipitate formed within 5 minutes
- stirringThe mixture was stirred at RT for 5 minutes
- stirringThe resulting suspension was stirred at RT overnight
- customThe solvent was evaporated
- customThe residue was purified by chromatography on silica gel (80 g cartridge)
- washwith gradient elution (100% A to 100% B over 16 column volumes)
- customto afford crude product which
- customwas further purified by preparative HPLC
出典と根拠
- ORDレコード
- ord-3803130d5664412cb87665a2a57c85cb
- 出典データセット
- uspto-grants-2015_06
- 特許番号
- US09062070B2
反応ノート
読み込み中…